Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Buy
+2,120
New +$262K 0.1% 70
2025
Q3
Sell
-818,808
Closed -$128M 1057
2025
Q2
$128M Sell
818,808
-294,654
-26% -$46.7M 0.37% 53
2025
Q1
$183M Sell
1,113,462
-255,955
-19% -$42.6M 0.6% 30
2024
Q4
$223M Buy
1,369,417
+117,724
+9% +$21.1M 0.68% 24
2024
Q3
$245M Sell
1,251,693
-49,592
-4% -$9.14M 0.72% 24
2024
Q2
$226M Buy
1,301,285
+126,070
+11% +$21M 0.67% 26
2024
Q1
$199M Buy
1,175,215
+118,819
+11% +$22.3M 0.6% 31
2023
Q4
$209M Buy
1,056,396
+115,702
+12% +$20.5M 0.67% 26
2023
Q3
$164M Buy
940,694
+64,762
+7% +$11.8M 0.58% 32
2023
Q2
$151M Buy
875,932
+110,816
+14% +$19.2M 0.5% 37
2023
Q1
$127M Sell
765,116
-55,241
-7% -$9.05M 0.44% 46
2022
Q4
$120M Buy
820,357
+18,110
+2% +$2.68M 0.43% 47
2022
Q3
$119M Sell
802,247
-19,366
-2% -$3.24M 0.47% 42
2022
Q2
$141M Buy
821,613
+29,299
+4% +$5.07M 0.52% 36
2022
Q1
$149M Sell
792,314
-56,131
-7% -$11.1M 0.42% 44
2021
Q4
$207M Sell
848,445
-98,105
-10% -$21.5M 0.53% 31
2021
Q3
$184M Buy
946,550
+6,534
+0.7% +$1.32M 0.52% 30
2021
Q2
$175M Buy
940,016
+28,319
+3% +$4.92M 0.49% 33
2021
Q1
$144M Buy
911,697
+73,243
+9% +$11.6M 0.44% 44
2020
Q4
$139M Buy
838,454
+117,523
+16% +$19.1M 0.44% 43
2020
Q3
$119M Buy
720,931
+35,004
+5% +$5.38M 0.43% 43
2020
Q2
$94M Sell
685,927
-7,750
-1% -$1.01M 0.37% 55
2020
Q1
$81.6M Buy
693,677
+27,562
+4% +$3.63M 0.41% 53
2019
Q4
$88.2M Buy
666,115
+81,077
+14% +$10.1M 0.36% 61
2019
Q3
$72.9M Buy
585,038
+10,594
+2% +$1.28M 0.29% 87
2019
Q2
$65.2M Buy
574,444
+141,480
+33% +$14.8M 0.25% 107
2019
Q1
$43.6M Buy
432,964
+9,857
+2% +$895K 0.17% 168
2018
Q4
$36.2M Buy
423,107
+88,996
+27% +$8.02M 0.16% 176
2018
Q3
$30.6M Buy
334,111
+84,618
+34% +$7.51M 0.11% 227
2018
Q2
$21.3M Sell
249,493
-24,691
-9% -$2.08M 0.08% 274
2018
Q1
$22.9M Buy
274,184
+15,500
+6% +$1.22M 0.09% 260
2017
Q4
$18.6M Buy
258,684
+6,443
+3% +$443K 0.07% 315
2017
Q3
$16.1M Buy
252,241
+33,227
+15% +$2.08M 0.07% 318
2017
Q2
$13.7M Sell
219,014
-23,817
-10% -$1.41M 0.06% 348
2017
Q1
$13M Buy
242,831
+1,900
+0.8% +$103K 0.06% 349
2016
Q4
$12.9M Buy
240,931
+46,931
+24% +$2.39M 0.06% 348
2016
Q3
$10.1M Buy
194,000
+11,800
+6% +$597K 0.04% 394
2016
Q2
$8.65M Buy
182,200
+15,300
+9% +$723K 0.04% 435
2016
Q1
$7.4M Sell
166,900
-12,900
-7% -$547K 0.03% 463
2015
Q4
$8.62M Buy
179,800
+1,500
+0.8% +$67.8K 0.04% 423
2015
Q3
$7.34M Buy
178,300
+35,200
+25% +$1.63M 0.03% 459
2015
Q2
$6.9M Buy
143,100
+140,200
+4,834% +$6.69M 0.03% 502
2015
Q1
$134K Buy
2,900
+1,500
+107% +$67.6K ﹤0.01% 1281
2014
Q4
$60K Hold
1,400
﹤0.01% 1345
2014
Q3
$52K Sell
1,400
-83,000
-98% -$2.84M ﹤0.01% 1350
2014
Q2
$2.72M Buy
+84,400
New +$2.59M 0.01% 696

Other funds holding ZTS

Axa's ZTS Position: Q1 2026 in Review

Axa opened a new position in Zoetis (ZTS) in Q1 2026: 2,120 shares worth $251K. The stake represents 0.1% of the portfolio and ranks #70 among its holdings. This is a return to the name: Axa previously reported a position in ZTS as recently as Q2 2025.

Axa first reported a position in ZTS in Q2 2014 and has held it in 46 quarters since. The position peaked at $245M in Q3 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Axa held 2,120 shares of Zoetis worth $251K as of Q1 2026.
  • Zoetis was a new Axa position in Q1 2026.
  • Zoetis made up 0.1% of Axa's portfolio in Q1 2026, its #70 holding.
  • Axa first reported a position in Zoetis in Q2 2014 and has held it in 46 quarters since.
  • Axa's Zoetis position peaked at $245M in Q3 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.